InventionMed Cash Flow Statement

Financials in millions PLN. Fiscal year is January - December.

Millions PLN. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2014	FY 2013
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013
Net Income	-1.3	-4.41	6.91	1.47
Depreciation & Amortization	0.89	0.85	0.01	0.04
Other Adjustments	1.6	1.91	-0.31	-0.09
Change in Receivables	0.16	3.97	0.06	-0.01
Changes in Accounts Payable	0.08	-0.87	0.04	-0.05
Changes in Other Operating Activities	-1.94	-0.62	-7.17	-1.37
Operating Cash Flow	-0.5	0.83	-0.46	-0.02
Operating Cash Flow Growth	-	-	-	-
Capital Expenditures	0.58	0.14	0.42	0.07
Purchases of Investments	0	0	2.17	4.09
Proceeds from Sale of Investments	0	0	2.23	3.99
Other Investing Activities	0	0	0.15	1.59
Investing Cash Flow	-0.58	-0.14	-0.36	-0.35
Long-Term Debt Issued	1.18	1.56	0.53	0.29
Long-Term Debt Repaid	0	2.26	0.18	0.04
Net Long-Term Debt Issued (Repaid)	1.18	3.82	0.71	0.34
Issuance of Common Stock	0	0	0.76	-
Net Common Stock Issued (Repurchased)	0	0	0.76	-
Other Financing Activities	0	0	0.11	0.29
Financing Cash Flow	1.18	-0.7	1.08	0.48
Net Cash Flow	0.1	-0	0.26	0.12
Free Cash Flow	0.08	0.97	-0.03	0.05
Free Cash Flow Growth	-91.33%	-	-	-
FCF Margin	2.11%	117.51%	-12.26%	13.56%
Free Cash Flow Per Share	0.00	0.05	-0.00	0.00
Levered Free Cash Flow	-0.5	-0.69	0.92	0.49
Unlevered Free Cash Flow	-0.11	-2.97	-6.82	-1.57